Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Eda Tanrıkulu Şimşek"'
Publikováno v:
Translational Oncology, Vol 20, Iss , Pp 101403- (2022)
Externí odkaz:
https://doaj.org/article/4086c0f00b0647a18eeb2aede7ab4485
Autor:
Eda Caliskan Yildirim, Elif Atag, Ezgi Coban, Olcun Umit Unal, Abdussamet Celebi, Murat Keser, Mehmet Uzun, Merve Keskinkilic, Eda Tanrikulu Simsek, Murat Sari, Tugba Yavuzsen
Publikováno v:
Breast, Vol 70, Iss , Pp 56-62 (2023)
Background: CDK4/6 inhibitors combined with endocrine therapy have significantly improved treatment outcomes for metastatic hormone receptor-positive (HR+) breast cancer patients. However, the impact of low HER2 expression on treatment response and p
Externí odkaz:
https://doaj.org/article/968ed83daa7545e0b6b5f0347defa3cf
Autor:
Tuğba AKIN TELLİ, Nalan AKGÜL BABACAN, Özkan ALAN, Mehmet Akif ÖZTÜRK, Rahib HASANOV, Sinan KOCA, Süleyman HALİL, Eda TANRIKULU ŞİMŞEK, Tuğba BAŞOĞLU, Özlem ERCELEP, Faysal DANE, Perran Fulden YUMUK
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 10, Iss 1, Pp 74-79 (2022)
Aim:DR-70 is a newly developed immunoassay that detects fibrin degradation products in blood. We aimed to evaluate ability of DR-70 in monitoring treatment response in advanced gastrointestinal (GI) cancers.Materials and Methods:We prospectively enro
Externí odkaz:
https://doaj.org/article/0eecd9d0c2d943feb4b11316cac36178
Autor:
Özkan ALAN, Özlem ERCELEP, Tuğba AKİN TELLİ, Eda TANRIKULU ŞİMŞEK, Rahib HASANOV, Tuğba BASOGLU, Mehmet Akif ÖZTÜRK, Serap KAYA, Nalan AKGUL BABACAN, Tunç LAÇİN, Emine BOZKURTLAR, Faysal DANE, Perran Fulden YUMUK
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 8, Iss 3, Pp 376-382 (2020)
Aim: Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancers. Although curative treatment is surgery in the early stages, disease relapse is common. In this study, we retrospectively evaluated the prognostic factors and outcomes of op
Externí odkaz:
https://doaj.org/article/3b461b5761e14dd396bd6eb9abbf448f
Autor:
Ozkan Alan, Tugba Akin Telli, Ozlem Ercelep, Eda Tanrikulu Simsek, Tugba Basoglu Tuylu, Aydan Mutis, Rahib Hasanov, Serap Kaya, Nalan Akgül Babacan, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
Journal of Medical Case Reports, Vol 12, Iss 1, Pp 1-5 (2018)
Abstract Background Chordoma is a rare malignant tumor of the skull base and axial skeleton, with an incidence of less than 0.1/100,000 per year. Patients with advanced chordoma have a poor prognosis due to locoregional recurrence with infiltration a
Externí odkaz:
https://doaj.org/article/bab79c9c4ed4436996ff2f10859b7947